Pathology & Oncology Research

, Volume 15, Issue 3, pp 369–374

CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer

  • Zhao-dong Han
  • Xue-cheng Bi
  • Wei-jun Qin
  • Hui-chan He
  • Qi-shan Dai
  • Jun Zou
  • Yong-kang Ye
  • Yu-xiang Liang
  • Guo-hua Zeng
  • Zhi-nan Chen
  • Wei-de Zhong
Original Paper

DOI: 10.1007/s12253-008-9131-z

Cite this article as:
Han, Z., Bi, X., Qin, W. et al. Pathol. Oncol. Res. (2009) 15: 369. doi:10.1007/s12253-008-9131-z

Abstract

Extracellular matrix metalloproteinase inducer (EMMPRIN, also named as CD147) is a multifunctional membrane glycoprotein over-expressed in many kinds of human solid tumors. It has been demonstrated to be involved in tumor invasion and angiogenesis. The aim of this study was to analyze the clinicopathological characteristics of the expression of CD147 in human prostate cancer (PCa), and to evaluate its clinical significance in the histologic classification and prognosis of PCa. CD147 protein expression in paraffin-embedded specimens gathered from 62 cases of PCa and 30 cases of benign prostatic hyperplasia (BPH) were detected by the method of immunohistochemistry. The association of CD147 protein expression with the clinicopathological characteristics and with the prognosis of PCa was subsequently assessed. CD147 expression were positively expressed in 51/62 (82.3%) of PCa and 4/30 (13.3%) of BPH cases, respectively. The positive expression rate of CD147 in PCa tissues was significantly higher than that in BPH. The positive expression of CD147 was dramatically associated with TNM grade (p < 0.001), the depth of the prostatic wall invasion (p = 0.008), GLEASON Score (p = 0.001) and Histologic grade (p = 0.001). The patients with CD147 expression were associated with a poor prognosis of PCa (p = 0.01) and the survival rate of the patients with a strong positive expression of CD147 was the lowest (p = 0.01). The results suggest that the expression of CD147 may be an important feature of PCa and the detection of its expression may benefit us in the prediction of the prognosis of PCa.

Keywords

Prostate cancer CD147 Clinical pathology Diagnosis Prognosis 

Copyright information

© Arányi Lajos Foundation 2008

Authors and Affiliations

  • Zhao-dong Han
    • 1
  • Xue-cheng Bi
    • 2
  • Wei-jun Qin
    • 3
  • Hui-chan He
    • 1
  • Qi-shan Dai
    • 1
  • Jun Zou
    • 1
  • Yong-kang Ye
    • 1
  • Yu-xiang Liang
    • 1
  • Guo-hua Zeng
    • 4
  • Zhi-nan Chen
    • 3
  • Wei-de Zhong
    • 1
    • 5
  1. 1.Guangzhou First Municipal People’s HospitalAffiliated Guangzhou Medical CollegeGuangzhouChina
  2. 2.Southern Medical UniversityGuangzhouChina
  3. 3.Department of Cell Biology & Cell Engineering Research CentreFourth Military Medical UniversityXi’anChina
  4. 4.First Affiliated Hospital of Guangzhou Medical CollegeGuangzhouChina
  5. 5.Department of Urology, Guangzhou First Municipal People’s Hospital, Southern Medical UniversityAffiliated Guangzhou Medical CollegeGuangzhouChina

Personalised recommendations